← Leaderboards
Noreen J Hickok
Thomas Jefferson University
$7,657,282
Attributed
$13,523,390
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,523,390 · 8
By mechanism
R01$13,368,106 · 7
P01$155,284 · 1
Top collaborators
- Christopher S Adams6 shared
- Paula Bourke5 shared
- Flemming Forsberg5 shared
- Theresa A Freeman5 shared
- Brendan Gilmore5 shared
- Christopher M Snyder3 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Paula Bourke$831,520
- Theresa A Freeman$1,916,808
- Brendan Gilmore$831,520
- Christopher M Snyder$6,371,518
- Lauren Jo Delaney$1,784,635
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Henry F Chambers · Duke University$84,838,080
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
Research focus
BacteriaAntimicrobialInfectionTissuesAnti-Bacterial AgentsMicrobial BiofilmsImplantAntibioticsAntibiotic TherapyCombatCellsProductionSurfaceOrthopedicsIn VitroIn VivoBasePreventEngineeringOperative Surgical ProceduresImmunePainBoneInfection Prevention
Grant awards (28)
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$638,200
R01 · FY2025 · AR
The joint environment and periprosthetic joint infection$611,177
R01 · FY2025 · AR · contact PI
The joint environment and periprosthetic joint infection$686,259
R01 · FY2024 · AR · contact PI
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$646,298
R01 · FY2024 · AR
The joint environment and periprosthetic joint infection$683,063
R01 · FY2023 · AR · contact PI
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$676,113
R01 · FY2022 · AR
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$662,652
R01 · FY2021 · AR
Synovial Fluid and Joint Sepsis$440,970
R01 · FY2021 · AR · contact PI
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$702,816
R01 · FY2020 · AR
Preventing Spinal Infection: Ultrasound Triggered Prophylaxis$520,892
R01 · FY2020 · AR · contact PI
Synovial Fluid and Joint Sepsis$484,576
R01 · FY2020 · AR · contact PI
Preventing Spinal Infection: Ultrasound Triggered Prophylaxis$520,892
R01 · FY2019 · AR · contact PI
Synovial Fluid and Joint Sepsis$513,872
R01 · FY2019 · AR · contact PI
Preventing Spinal Infection: Ultrasound Triggered Prophylaxis$535,192
R01 · FY2018 · AR · contact PI
Synovial Fluid and Joint Sepsis$513,872
R01 · FY2018 · AR · contact PI
Synovial Fluid and Joint Sepsis$540,457
R01 · FY2017 · AR · contact PI
Preventing Spinal Infection: Ultrasound Triggered Prophylaxis$483,330
R01 · FY2017 · AR · contact PI
Preventing Spinal Infection: Ultrasound Triggered Prophylaxis$502,716
R01 · FY2016 · AR · contact PI
Creating an Infection-Free Intraosseus Transcutaneous Amputation Prosthesis$316,854
R01 · FY2012 · HD · contact PI
Creating an Infection-Free Intraosseus Transcutaneous Amputation Prosthesis$317,715
R01 · FY2011 · HD · contact PI
A new allograft that promotes long-term, infection-free skeletal repair$435,901
R01 · FY2010 · DE · contact PI
Creating an Infection-Free Intraosseus Transcutaneous Amputation Prosthesis$336,353
R01 · FY2010 · HD · contact PI
A new allograft that promotes long-term, infection-free skeletal repair$439,379
R01 · FY2009 · DE · contact PI
Creating an Infection-Free Intraosseus Transcutaneous Amputation Prosthesis$353,375
R01 · FY2009 · HD · contact PI
EXON-SPECIFIC FIBRONECTIN ISOFORMS AND CHONDROGENESIS$275,156
R01 · FY2003 · AR
EXON-SPECIFIC FIBRONECTIN ISOFORMS AND CHONDROGENESIS$268,704
R01 · FY2002 · AR
Core--Morphology and biomechanics$155,284
P01 · FY2002 · AR
EXON-SPECIFIC FIBRONECTIN ISOFORMS AND CHONDROGENESIS$261,322
R01 · FY2001 · AR